Get the Stockscreener App
0.4393
31.34%
-0.2005
After Hours:
.44
0.0007
+0.16%
Bionomics Ltd Adr stock is traded at $0.4393, with a volume of 1.35M.
It is down -31.34% in the last 24 hours and down -31.63% over the past month.
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.
See More
Previous Close:
$0.6398
Open:
$0.654
24h Volume:
1.35M
Relative Volume:
1.51
Market Cap:
$5.72M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-0.1349
EPS:
-3.2558
Net Cash Flow:
-
1W Performance:
-28.84%
1M Performance:
-31.63%
6M Performance:
-57.35%
1Y Performance:
-83.73%
1-Day Range:
$0.42
$0.655
1-Week Range:
$0.42
$0.668
52-Week Range:
$0.42
$5.30
Bionomics Ltd Adr Stock (BNOX) Company Profile
Bionomics Ltd Adr Stock (BNOX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-22 | Initiated | Berenberg | Buy |
| Jan-10-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-10-22 | Initiated | Evercore ISI | Outperform |
| Jan-10-22 | Initiated | H.C. Wainwright | Buy |
Bionomics Ltd Adr Stock (BNOX) Latest News
Market Watch: Bionomics Ltd. ADR (BNOX)’s Noteworthy Drop, Closing at 0.64 - The Dwinnex
Bionomics Ltd. ADR (BNOX) stock analysis: A simple moving average approach - US Post News
Ratio Analysis: Unpacking Bionomics Ltd. ADR (BNOX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Is it possible to buy Bionomics Ltd. ADR(BNOX) shares at a good price now? - US Post News
Investor’s Toolkit: Key Ratios for Assessing Bionomics Ltd. ADR (BNOX)’s Performance - The Dwinnex
Recursion Pharmaceuticals Inc (RXRX) Has Recovered 32.29% From Its Low: Is This The Beginning Of A Trend? - Stocks Register
An analyst sees good growth prospects for Bionomics Ltd. ADR (BNOX) - SETE News
Bionomics Ltd. ADR [BNOX] Stock trading around $0.83 per share: What’s Next? - The DBT News
Bionomics Ltd. ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle
Bionomics Ltd. ADR (BNOX) Stock: A Year of Decreases and Increases - The InvestChronicle
Nauticus Robotics Inc [KITT] Stock trading around $0.13 per share: What’s Next? - The DBT News
Chuy’s Holdings Inc [CHUY] fell -2.33% so far this year. What now? - The DBT News
Market cap of Kintara Therapeutics Inc [KTRA] reaches 15.16M – now what? - The DBT News
Bionomics Ltd. ADR Inc. (BNOX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Bionomics commences phase 3 trial for social anxiety treatment - Investing.com
Bionomics faces Nasdaq delisting over share price - Investing.com
Stock Market Recap: Bionomics Ltd. ADR (BNOX) Concludes at 0.69, a -2.76 Surge/Decline – DWinneX - The Dwinnex
Results from Bionomics Ltd. ADR (BNOX) show potential – US Post News - US Post News
Bionomics stock retains Buy rating from H.C. Wainwright By Investing.com - Investing.com
Bionomics Ltd. ADR's latest rating changes from various analysts – Knox Daily - Knox Daily
Closing Bell Recap: Bionomics Ltd. ADR (BNOX) Ends at 0.84, Reflecting a -14.97 Downturn – DWinneX - The Dwinnex
BNOX’s Stochastic Averages Dip: Analyzing Bionomics Ltd. ADR’s Stock Performance - The InvestChronicle
Bionomics secures $70 million in private placement By Investing.com - Investing.com
BNOX's price-to-free cash flow ratio: What it means for investors – US Post News - US Post News
Bionomics secures $70 million in private placement - Investing.com
Ratios Reveal: Breaking Down Bionomics Ltd. ADR (BNOX)'s Financial Health – DWinneX - The Dwinnex
There is no doubt that Bionomics Ltd. ADR (BNOX) ticks all the boxes. – Sete News - SETE News
Bears are Losing Control Over Bionomics Limited Unsponsored ADR (BNOX), Here's Why It's a 'Buy' Now - Yahoo Movies Canada
Bionomics Ltd. ADR (BNOX) Stock: Navigating a Year of Volatility - The InvestChronicle
Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting - GlobeNewswire Inc.
Bears are Losing Control Over Bionomics Limited Unsponsored ADR (BNOX), Here's Why It's a 'Buy' Now - Yahoo Singapore News
Bionomics reports promising PTSD treatment trial results By Investing.com - Investing.com
10 Best Australian Stocks To Buy - Yahoo Finance
Bionomics (BNOX) Meets Goals in PTSD Study, Stock Rallies 244% - Nasdaq
Bionomics (BNOX) Up on Positive Updates on PTSD & SAD Candidate - Zacks Investment Research
Rise and Shine: Everything you need to know before the ASX opens - Stockhead
Bionomics (BNOX) Stock Price, News & Analysis - MarketBeat
Check-up: What's happening with the ASX small cap health stocks? - Stockhead
Bionomics Ltd Adr Stock (BNOX) Financials Data
There is no financial data for Bionomics Ltd Adr (BNOX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):